| Structure |
Chemical Name |
CAS |
MF |
 |
AZD4547 (FGFR inhibitor) |
|
|
 |
プマプラゾール |
158364-59-1 |
C19H22N4O2 |
|
|
ACP-196 (BTK inhibitor) |
|
|
 |
N-フェニル-2,3-ビス(2-メトキシフェニル)-1,2,4-チアジアゾール-5(2H)-イミン |
524923-88-4 |
C22H19N3O2S |
 |
1-ナフチルアセチルスペルミン 三塩酸塩 |
1049731-36-3 |
C22H35ClN4O |
|
|
VENETOCLAX (ABT-199, GDC-0199) (BCL-2 inhibitor) |
|
|
|
|
(-)-BLEBBISTATIN (ATPASE inhibitor) |
|
|
 |
TB500 |
885340-08-9 |
C38H68N10O14 |
|
|
VINCRISTINE (MICROTUBULE ASSOSIATED inhibitor) |
|
|
|
|
COMBRETASTATIN A4 (MICROTUBULE ASSOCIATED inhibitor) |
|
|
|
|
Kidney function biochemical test kit |
|
|
 |
1-メチル-3-カルバモイルピリジニウム·ヨージド |
6456-44-6 |
C7H9IN2O |
|
|
Active Motif |
|
|
|
|
ISRIB (PERK inhibitor) |
|
|
|
|
ENDOFECTIN MAX Transfection Reagent |
|
|
|
|
RG108 (DNA METHYLTRANSFERASE inhibitor) |
|
|
|
|
VILAZODONE (SSRI inhibitor) |
|
|
 |
2-メチルイソチアゾロン塩酸塩 |
26172-54-3 |
C4H6ClNOS |
|
|
ENTOSPLETINIB (SYK inhibitor) |
|
|
|
|
BCIP/NBT alkaline phosphatase substrate solution |
|
|
|
|
WESTERN antibody eluate |
|
|
|
|
VOLASERTIB (PLK inhibitor) |
|
|
 |
Nexopamil (racemate) |
116759-35-4 |
C24H40N2O3 |
|
|
Electrolyte biochemical test kit |
|
|
![L-Tyrosine, O-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-](/CAS/20210111/GIF/1219629-36-3.gif) |
L-Tyrosine, O-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]- |
1219629-36-3 |
C16H24N2O5 |
|
|
Hoechst fluorescent dye 33258 |
|
|
|
|
TWS119 (GSK-3 inhibitor) |
|
|
|
|
TIVOZANIB (VEGFR inhibitor) |
|
|
|
|
ABT-199 (BCL-2 inhibitor) |
|
|
|
|
TAE (50X) |
|
|
|
|
ODANACATIB (CYSTEINE PROTEASE inhibitor) |
|
|
 |
タフトシン |
9063-57-4 |
C21H40N8O6 |
 |
パロノセトロン |
135729-61-2 |
C19H24N2O |
|
|
Glucose metabolism biochemical detection kit |
|
|
|
|
REMODELIN (HISTONE ACETYLTRANSFERASE inhibitor) |
|
|
|
|
Antibody dilution |
|
|
|
|
FK-506 (MTOR inhibitor) |
|
|
|
|
Chemiluminescent reagents |
|
|
|
|
BD FACS Clean Solution |
|
|
|
|
DL2000 DNA Marker |
|
|
|
|
DAPT (Γ-SECRETASE inhibitor) |
|
|
 |
Exatecan mesylate |
169869-90-3 |
C25H26FN3O7S |
![3-Azetidinecarboxamide, 1-(aminosulfonyl)-N-(6-chloro-4-methoxy-3-pyridinyl)-3-[2-(1-methylethyl)phenyl]-](/CAS/20210305/GIF/2569467-78-1.gif) |
3-Azetidinecarboxamide, 1-(aminosulfonyl)-N-(6-chloro-4-methoxy-3-pyridinyl)-3-[2-(1-methylethyl)phenyl]- |
2569467-78-1 |
C19H23ClN4O4S |
 |
PSD506 |
754177-77-0 |
C22H37N3O3S |
|
|
RNasin Inhibitor (Ribonuclease Inhibitor)) |
|
|
 |
Tedalinab |
916591-01-0 |
C19H21F2N3O |
 |
(S,S)-ICG001 |
847591-62-2 |
C33H32N4O4 |
|
|
TG101348 (JAK inhibitor) |
|
|
|
|
PND-1186 (FAK inhibitor) |
|
|
|
|
AG14361 (PARP1 inhibitor) |
|
|
 |
N-CIS-2,6-ジメチルピペリジノカルボニル-Β-TBU-ALA-D-TRP(1-メトキシカルボニル)-D-NLE-OH |
173326-37-9 |
C34H51N5O7 |
|
|
PI-103 (PI3K inhibitor) |
|
|
 |
重マレイン酸セロトニン |
18525-25-2 |
C14H16N2O5 |
|
|
DEGRASYN (BCR-ABL inhibitor) |
|
|
|
|
KU0063794 (MTOR inhibitor) |
|
|
 |
AB 928 |
2239273-34-6 |
C23H22N8O |
|
|
B-27 serum-free additive, 50X, no vitamin A |
|
|
 |
MAL-PEG5-NHSエステル |
1807537-42-3 |
C21H30N2O11 |
 |
1-(2-シクロプロピルフェノキシ)-3-(イソプロピルアミノ)-2-プロパノール |
27325-36-6 |
C15H23NO2 |
![5'-O-[ビス(4-メトキシフェニル)フェニルメチル]-2'-デオキシ-N-メチルアデノシン](/CAS/GIF/98056-69-0.gif) |
5'-O-[ビス(4-メトキシフェニル)フェニルメチル]-2'-デオキシ-N-メチルアデノシン |
98056-69-0 |
C32H33N5O5 |
 |
HYDROXYLAMINE HYDROCHLORIDE/Hydroxylamine Hydrochloride |
|
Cl2H8N2O2 |
|
|
People lymphocyte separation fluid |
|
|
|
|
JNJ-7777120 (HISTAMINE RECEPTOR antagonist) |
|
|
|
|
0.9% saline |
|
|
|
|
EMPAGLIFLOZIN (SGLT inhibitor) |
|
|
 |
ML 145 |
1164500-72-4 |
C24H22N2O5S2 |
 |
BQ-788ナトリウム塩 |
156161-89-6 |
C34H52N5NaO7 |
|
|
PFI-3 (EPIGENETIC READER DOMAIN inhibitor) |
|
|
|
|
0.25% trypsin solution (containing EDTA and phenol red, dissolved in PBS) |
|
|
![2H-Pyran-4-propanamide, α-[4-(cyclopropylsulfonyl)phenyl]-N-(5-fluoro-2-thiazolyl)tetrahydro-, (αR)-](/CAS/20211123/GIF/745051-61-0.gif) |
2H-Pyran-4-propanamide, α-[4-(cyclopropylsulfonyl)phenyl]-N-(5-fluoro-2-thiazolyl)tetrahydro-, (αR)- |
745051-61-0 |
C20H23FN2O4S2 |
 |
2-(アセチルアミノ)-6-クロロ-9H-プリン |
7602-01-9 |
C7H6ClN5O |
|
|
Myocardial biochemical test kit |
|
|
|
|
ML141 (RHO inhibitor) |
|
|
|
|
ROMIDEPSIN (HDAC inhibitor) |
|
|
 |
レリセトロン |
143257-98-1 |
C18H20N4 |
|
|
DABRAFENIB (RAF inhibitor) |
|
|
|
|
SALUBRINAL (PERK inhibitor) |
|
|
![6-ベンジル-5,6,7,8-テトラヒドロピリド[4,3-D]ピリミジン-4(3H)-オン](/CAS/GIF/109229-22-3.gif) |
6-ベンジル-5,6,7,8-テトラヒドロピリド[4,3-D]ピリミジン-4(3H)-オン |
109229-22-3 |
C14H15N3O |
|
|
ICOTINIB HCL (EGFR inhibitor) |
|
|
|
|
Protein protectant TY |
|
|
|
|
Copper extractant LIX984 |
|
|
|
|
AVASIMIBE (P450 inhibitor) |
|
|
 |
3β-ヒドロキシ-20-オキソプレグナ-5-エン-16α-カルボニトリル |
1434-54-4 |
C22H31NO2 |
|
|
EPZ-6438 (E7438) (EZH2 inhibitor) |
|
|
|
|
INDIPLON (GABA RECEPTOR Conditioner) |
|
|
|
|
Precipitate TMB solutions |
|
|
|
|
AR-A014418 (GSK-3 inhibitor) |
|
|
 |
ホスアプレピタント |
172673-20-0 |
C23H22F7N4O6P |
|
|
PURMORPHAMINE (HEDGEHOG/SMOOTHENED agonist) |
|
|
![4'-[(2-エトキシ-4-エチル-5-{[(2S)-4-メチル-2-スルファニルペンタンアミド]メチル}イミダゾール-1-イル)メチル]-3'-フルオロ-[1,1'-ビフェニル]-2-カルボン酸](/CAS/20200515/GIF/1073549-10-6.gif) |
4'-[(2-エトキシ-4-エチル-5-{[(2S)-4-メチル-2-スルファニルペンタンアミド]メチル}イミダゾール-1-イル)メチル]-3'-フルオロ-[1,1'-ビフェニル]-2-カルボン酸 |
1073549-10-6 |
C28H34FN3O4S |
|
|
Maleic anhydride graft compatibilizer |
|
|
|
|
SALIRASIB (RHO inhibitor) |
|
|
|
|
Penicillin-Streptomycin for Cell Culture |
|
|
 |
エファロキサン 塩酸塩 |
89197-00-2 |
C13H17ClN2O |
|
|
BMS-5 (LIMK inhibitor) |
|
|
|
|
BKM120 (PI3K inhibitor) |
|
|
 |
ゲファピクサント |
1015787-98-0 |
C14H19N5O4S |
 |
フィネレノン |
1050477-31-0 |
C21H22N4O3 |
|
|
30% Acr-Bis (29:1) |
|
|
|
|
RIMONABANT (CANNABINOID RECEPTOR antagonist) |
|
|